Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sammy Saab

Showing results (301-310 of 340) with videos related to

Pageof 34
Sort By:
Clinical Transplantation|October 26, 2019
Long-term outcomes with oral therapy in liver transplant recipients with hepatitis BSammy Saab, Dana Song, Youssef P Challita, et al.
The American Journal of Gastroenterology|May 7, 2004
Fulminant liver failure due to usnic acid for weight lossFrancisco A Durazo, Charles Lassman, Steven H B Han, et al.
Phytotherapy Research : PTR|December 2, 2015
A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis CNu T Lu, Catherine M Crespi, Natalie M Liu, et al.
Hepatology (Baltimore, Md.)|July 24, 2012
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantationGregory T Everson, Norah A Terrault, Anna S Lok, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis CMitsugi Shimoda, Rafik M Ghobrial, Ian C Carmody, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 16, 2013
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analoguesJeffrey Campsen, Michael Zimmerman, James Trotter, et al.
Advances in Therapy|October 27, 2021
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019Nancy Reau, Mark S Sulkowski, Emmanuel Thomas, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation studyNorah A Terrault, R Todd Stravitz, Anna S F Lok, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 29, 2006
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantationNorah A Terrault, Mitchell L Shiffman, Anna S F Lok, et al.
Annals of Surgery|September 26, 2006
Effect of nonviral factors on hepatitis C recurrence after liver transplantationAndrew M Cameron, Rafik M Ghobrial, Jonathan R Hiatt, et al.
Pageof 34

Showing results (301-310 of 340) with videos related to

Sort By:
Pageof 34
Clinical Transplantation|October 26, 2019
Long-term outcomes with oral therapy in liver transplant recipients with hepatitis BSammy Saab, Dana Song, Youssef P Challita, et al.
The American Journal of Gastroenterology|May 7, 2004
Fulminant liver failure due to usnic acid for weight lossFrancisco A Durazo, Charles Lassman, Steven H B Han, et al.
Phytotherapy Research : PTR|December 2, 2015
A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis CNu T Lu, Catherine M Crespi, Natalie M Liu, et al.
Hepatology (Baltimore, Md.)|July 24, 2012
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantationGregory T Everson, Norah A Terrault, Anna S Lok, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis CMitsugi Shimoda, Rafik M Ghobrial, Ian C Carmody, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 16, 2013
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analoguesJeffrey Campsen, Michael Zimmerman, James Trotter, et al.
Advances in Therapy|October 27, 2021
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019Nancy Reau, Mark S Sulkowski, Emmanuel Thomas, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation studyNorah A Terrault, R Todd Stravitz, Anna S F Lok, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 29, 2006
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantationNorah A Terrault, Mitchell L Shiffman, Anna S F Lok, et al.
Annals of Surgery|September 26, 2006
Effect of nonviral factors on hepatitis C recurrence after liver transplantationAndrew M Cameron, Rafik M Ghobrial, Jonathan R Hiatt, et al.
Pageof 34